A citation-based method for searching scientific literature

Magdalini Sachana, Anna Bal-Price, Kevin M Crofton, Susanne H Bennekou, Timothy J Shafer, Mamta Behl, Andrea Terron. Toxicol Sci 2019
Times Cited: 34







List of co-cited articles
274 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Recommendation on test readiness criteria for new approach methods in toxicology: Exemplified for developmental neurotoxicity.
Anna Bal-Price, Helena T Hogberg, Kevin M Crofton, Mardas Daneshian, Rex E FitzGerald, Ellen Fritsche, Tuula Heinonen, Susanne Hougaard Bennekou, Stefanie Klima, Aldert H Piersma,[...]. ALTEX 2018
85
64

Consensus statement on the need for innovation, transition and implementation of developmental neurotoxicity (DNT) testing for regulatory purposes.
Ellen Fritsche, Philippe Grandjean, Kevin M Crofton, Michael Aschner, Alan Goldberg, Tuula Heinonen, Ellen V S Hessel, Helena T Hogberg, Susanne Hougaard Bennekou, Pamela J Lein,[...]. Toxicol Appl Pharmacol 2018
74
61

Reference compounds for alternative test methods to indicate developmental neurotoxicity (DNT) potential of chemicals: example lists and criteria for their selection and use.
Michael Aschner, Sandra Ceccatelli, Mardas Daneshian, Ellen Fritsche, Nina Hasiwa, Thomas Hartung, Helena T Hogberg, Marcel Leist, Abby Li, William R Mundi,[...]. ALTEX 2017
82
50


OECD/EFSA workshop on developmental neurotoxicity (DNT): The use of non-animal test methods for regulatory purposes.
Ellen Fritsche, Kevin M Crofton, Antonio F Hernandez, Susanne Hougaard Bennekou, Marcel Leist, Anna Bal-Price, Elissa Reaves, Martin F Wilks, Andrea Terron, Roland Solecki,[...]. ALTEX 2017
57
41

Strategies to improve the regulatory assessment of developmental neurotoxicity (DNT) using in vitro methods.
Anna Bal-Price, Francesca Pistollato, Magdalini Sachana, Stephanie K Bopp, Sharon Munn, Andrew Worth. Toxicol Appl Pharmacol 2018
67
41

Neurobehavioural effects of developmental toxicity.
Philippe Grandjean, Philip J Landrigan. Lancet Neurol 2014
899
35

Developmental neurotoxicity testing: a path forward.
Kevin M Crofton, William R Mundy, Timothy J Shafer. Congenit Anom (Kyoto) 2012
72
35

International STakeholder NETwork (ISTNET): creating a developmental neurotoxicity (DNT) testing road map for regulatory purposes.
Anna Bal-Price, Kevin M Crofton, Marcel Leist, Sandra Allen, Michael Arand, Timo Buetler, Nathalie Delrue, Rex E FitzGerald, Thomas Hartung, Tuula Heinonen,[...]. Arch Toxicol 2015
99
35

Expanding the test set: Chemicals with potential to disrupt mammalian brain development.
William R Mundy, Stephanie Padilla, Joseph M Breier, Kevin M Crofton, Mary E Gilbert, David W Herr, Karl F Jensen, Nicholas M Radio, Kathleen C Raffaele, Kelly Schumacher,[...]. Neurotoxicol Teratol 2015
54
35

Testing for developmental neurotoxicity using a battery of in vitro assays for key cellular events in neurodevelopment.
Joshua A Harrill, Theresa Freudenrich, Kathleen Wallace, Kenneth Ball, Timothy J Shafer, William R Mundy. Toxicol Appl Pharmacol 2018
36
32


Assessment of developmental neurotoxicity induced by chemical mixtures using an adverse outcome pathway concept.
Francesca Pistollato, Emilio Mendoza de Gyves, Donatella Carpi, Stephanie K Bopp, Carolina Nunes, Andrew Worth, Anna Bal-Price. Environ Health 2020
35
29

Developmental neurotoxicity testing: recommendations for developing alternative methods for the screening and prioritization of chemicals.
Kevin M Crofton, William R Mundy, Pamela J Lein, Anna Bal-Price, Sandra Coecke, Andrea E M Seiler, Holger Knaut, Leonora Buzanska, Alan Goldberg. ALTEX 2011
109
26

Developmental neurotoxicity - challenges in the 21st century and in vitro opportunities.
Lena Smirnova, Helena T Hogberg, Marcel Leist, Thomas Hartung. ALTEX 2014
94
26

Current Availability of Stem Cell-Based In Vitro Methods for Developmental Neurotoxicity (DNT) Testing.
Ellen Fritsche, Marta Barenys, Jördis Klose, Stefan Masjosthusmann, Laura Nimtz, Martin Schmuck, Saskia Wuttke, Julia Tigges. Toxicol Sci 2018
28
28


Developmental neurotoxicity of industrial chemicals.
P Grandjean, P J Landrigan. Lancet 2006
23


A transcriptome comparison of time-matched developing human, mouse and rat neural progenitor cells reveals human uniqueness.
Stefan Masjosthusmann, Daniel Becker, Barbara Petzuch, Jördis Klose, Clara Siebert, Rene Deenen, Marta Barenys, Jenny Baumann, Katharina Dach, Julia Tigges,[...]. Toxicol Appl Pharmacol 2018
16
43

Adverse outcome pathways: a conceptual framework to support ecotoxicology research and risk assessment.
Gerald T Ankley, Richard S Bennett, Russell J Erickson, Dale J Hoff, Michael W Hornung, Rodney D Johnson, David R Mount, John W Nichols, Christine L Russom, Patricia K Schmieder,[...]. Environ Toxicol Chem 2010
20

Comparative human and rat neurospheres reveal species differences in chemical effects on neurodevelopmental key events.
Jenny Baumann, Kathrin Gassmann, Stefan Masjosthusmann, Denise DeBoer, Farina Bendt, Susanne Giersiefer, Ellen Fritsche. Arch Toxicol 2016
51
20

Advancing the science of developmental neurotoxicity (DNT): testing for better safety evaluation.
Anna K Bal-Price, Sandra Coecke, Lucio Costa, Kevin M Crofton, Ellen Fritsche, Alan Goldberg, Philippe Grandjean, Pamela J Lein, Abby Li, Roberto Lucchini,[...]. ALTEX 2012
78
17

Editor's Highlight: Evaluation of a Microelectrode Array-Based Assay for Neural Network Ontogeny Using Training Set Chemicals.
Jasmine P Brown, Diana Hall, Christopher L Frank, Kathleen Wallace, William R Mundy, Timothy J Shafer. Toxicol Sci 2016
30
20

Neurite outgrowth in human induced pluripotent stem cell-derived neurons as a high-throughput screen for developmental neurotoxicity or neurotoxicity.
Kristen R Ryan, Oksana Sirenko, Fred Parham, Jui-Hua Hsieh, Evan F Cromwell, Raymond R Tice, Mamta Behl. Neurotoxicology 2016
82
17

Meeting report: alternatives for developmental neurotoxicity testing.
Pamela Lein, Paul Locke, Alan Goldberg. Environ Health Perspect 2007
80
17

In vitro acute and developmental neurotoxicity screening: an overview of cellular platforms and high-throughput technical possibilities.
Béla Z Schmidt, Martin Lehmann, Simon Gutbier, Erastus Nembo, Sabrina Noel, Lena Smirnova, Anna Forsby, Jürgen Hescheler, Hasan X Avci, Thomas Hartung,[...]. Arch Toxicol 2017
83
17

Towards a regulatory use of alternative developmental neurotoxicity testing (DNT).
Andrea Terron, Susanne Hougaard Bennekou. Toxicol Appl Pharmacol 2018
12
50


Evaluation of Chemical Effects on Network Formation in Cortical Neurons Grown on Microelectrode Arrays.
Timothy J Shafer, Jasmine P Brown, Brittany Lynch, Sylmarie Davila-Montero, Kathleen Wallace, Katie Paul Friedman. Toxicol Sci 2019
16
37

Characterization and application of electrically active neuronal networks established from human induced pluripotent stem cell-derived neural progenitor cells for neurotoxicity evaluation.
Laura Nimtz, Julia Hartmann, Julia Tigges, Stefan Masjosthusmann, Martin Schmuck, Eike Keßel, Stephan Theiss, Karl Köhrer, Patrick Petzsch, James Adjaye,[...]. Stem Cell Res 2020
14
42



A human brain microphysiological system derived from induced pluripotent stem cells to study neurological diseases and toxicity.
David Pamies, Paula Barreras, Katharina Block, Georgia Makri, Anupama Kumar, Daphne Wiersma, Lenna Smirnova, Ce Zang, Joseph Bressler, Kimberly M Christian,[...]. ALTEX 2017
107
14

Use of high content image analysis to detect chemical-induced changes in synaptogenesis in vitro.
Joshua A Harrill, Brian L Robinette, William R Mundy. Toxicol In Vitro 2011
76
14

Screening for Developmental Neurotoxicity at the National Toxicology Program: The Future Is Here.
Mamta Behl, Kristen Ryan, Jui-Hua Hsieh, Frederick Parham, Andrew J Shapiro, Bradley J Collins, Nisha S Sipes, Linda S Birnbaum, John R Bucher, Paul M D Foster,[...]. Toxicol Sci 2019
18
27

Development of the Concept for Stem Cell-Based Developmental Neurotoxicity Evaluation.
Ellen Fritsche, Marta Barenys, Jördis Klose, Stefan Masjosthusmann, Laura Nimtz, Martin Schmuck, Saskia Wuttke, Julia Tigges. Toxicol Sci 2018
19
26

Human Induced Pluripotent Stem Cell-Derived 3D-Neurospheres are Suitable for Neurotoxicity Screening.
Julianna Kobolak, Annamaria Teglasi, Tamas Bellak, Zofia Janstova, Kinga Molnar, Melinda Zana, Istvan Bock, Lajos Laszlo, Andras Dinnyes. Cells 2020
20
25

Development and analysis of an adverse outcome pathway network for human neurotoxicity.
Nicoleta Spinu, Anna Bal-Price, Mark T D Cronin, Steven J Enoch, Judith C Madden, Andrew P Worth. Arch Toxicol 2019
40
14

Human neurospheres as three-dimensional cellular systems for developmental neurotoxicity testing.
Michaela Moors, Thomas Dino Rockel, Josef Abel, Jason E Cline, Kathrin Gassmann, Timm Schreiber, Janette Schuwald, Nicole Weinmann, Ellen Fritsche. Environ Health Perspect 2009
121
14

Stem Cell-Derived Immature Human Dorsal Root Ganglia Neurons to Identify Peripheral Neurotoxicants.
Lisa Hoelting, Stefanie Klima, Christiaan Karreman, Marianna Grinberg, Johannes Meisig, Margit Henry, Tamara Rotshteyn, Jörg Rahnenführer, Nils Blüthgen, Agapios Sachinidis,[...]. Stem Cells Transl Med 2016
44
14

Omnisphero: a high-content image analysis (HCA) approach for phenotypic developmental neurotoxicity (DNT) screenings of organoid neurosphere cultures in vitro.
Martin R Schmuck, Thomas Temme, Katharina Dach, Denise de Boer, Marta Barenys, Farina Bendt, Axel Mosig, Ellen Fritsche. Arch Toxicol 2017
43
14

TBBPA targets converging key events of human oligodendrocyte development resulting in two novel AOPs
Jördis Klose, Julia Tigges, Stefan Masjosthusmann, Katharina Schmuck, Farina Bendt, Ulrike Hübenthal, Patrick Petzsch, Karl Köhrer, Katharina Koch, Ellen Fritsche. ALTEX 2021
10
50

The Next Generation Blueprint of Computational Toxicology at the U.S. Environmental Protection Agency.
Russell S Thomas, Tina Bahadori, Timothy J Buckley, John Cowden, Chad Deisenroth, Kathie L Dionisio, Jeffrey B Frithsen, Christopher M Grulke, Maureen R Gwinn, Joshua A Harrill,[...]. Toxicol Sci 2019
138
14

Workgroup report: incorporating in vitro alternative methods for developmental neurotoxicity into international hazard and risk assessment strategies.
Sandra Coecke, Alan M Goldberg, Sandra Allen, Leonora Buzanska, Gemma Calamandrei, Kevin Crofton, Lars Hareng, Thomas Hartung, Holger Knaut, Paul Honegger,[...]. Environ Health Perspect 2007
120
11


In vitro and other alternative approaches to developmental neurotoxicity testing (DNT).
Pamela Lein, Ellen Silbergeld, Paul Locke, Alan M Goldberg. Environ Toxicol Pharmacol 2005
79
11

Developing and applying the adverse outcome pathway concept for understanding and predicting neurotoxicity.
Anna Bal-Price, Pamela J Lein, Kimberly P Keil, Sunjay Sethi, Timothy Shafer, Marta Barenys, Ellen Fritsche, Magdalini Sachana, M E Bette Meek. Neurotoxicology 2017
51
11

Applying Adverse Outcome Pathways (AOPs) to support Integrated Approaches to Testing and Assessment (IATA).
Knut Erik Tollefsen, Stefan Scholz, Mark T Cronin, Stephen W Edwards, Joop de Knecht, Kevin Crofton, Natalia Garcia-Reyero, Thomas Hartung, Andrew Worth, Grace Patlewicz. Regul Toxicol Pharmacol 2014
201
11

BDE-99 impairs differentiation of human and mouse NPCs into the oligodendroglial lineage by species-specific modes of action.
Katharina Dach, Farina Bendt, Ulrike Huebenthal, Susanne Giersiefer, Pamela J Lein, Heike Heuer, Ellen Fritsche. Sci Rep 2017
32
12


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.